Holen Sie sich die Stockscreener-App
70.92
1.90%
-1.37
Finanzdaten der Tarsus Pharmaceuticals Inc-Aktie (TARS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
7.32%
173.91
|
162.05 | 151.67 | 118.70 | 102.66 |
| Cost Of Revenue |
28.92%
12.11
|
9.396 | - | - | - |
Selling, General, and Administrative
|
10.46%
150.70
|
136.43 | - | - | - |
| Costs And Expenses |
15.25%
193.82
|
168.18 | 159.64 | 133.23 | 124.84 |
| Operating Income/Loss |
225.19%
-19.91
|
-6.122 | -7.976 | -14.53 | -22.18 |
| Nonoperating Income/Loss |
170.27%
4.073
|
1.507 | 1.662 | 1.944 | 1.844 |
| Income Tax Expense/Benefit |
15.48%
2.716
|
2.352 | - | - | - |
| Net Income/Loss |
166.27%
-18.55
|
-6.967 | -8.373 | -12.59 | -20.34 |
| Basic Average Shares |
1.02%
43.39
|
42.96 | 0.327 | 42.61 | 42.36 |
| Diluted Average Shares |
1.02%
43.39
|
42.96 | 0.327 | 42.61 | 42.36 |
| Basic Earnings Per Share |
168.75%
-0.43
|
-0.16 | -0.19 | -0.30 | -0.48 |
| Diluted Earnings Per Share |
168.75%
-0.43
|
-0.16 | -0.19 | -0.30 | -0.48 |
2.30%
0.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):